Compare OVLY & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVLY | HUMA |
|---|---|---|
| Founded | 1990 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.7M | 182.6M |
| IPO Year | 2008 | N/A |
| Metric | OVLY | HUMA |
|---|---|---|
| Price | $32.90 | $1.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 15.7K | ★ 5.9M |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.12 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $731.05 |
| P/E Ratio | $15.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.70 | $0.88 |
| 52 Week High | $34.16 | $3.35 |
| Indicator | OVLY | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 58.14 |
| Support Level | $32.81 | $0.92 |
| Resistance Level | $34.08 | $1.26 |
| Average True Range (ATR) | 0.71 | 0.09 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 51.55 | 68.52 |
Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.